Silo Pharma (SILO) Payables (2011 - 2026)
Silo Pharma (SILO) posted Payables of $632743.0 for Q1 2026, up 9.46% sequentially from $578081.0 in Q4 2025, and down 43.16% YoY from $1.1 million in Q1 2025.
Silo Pharma (SILO) Payables (2011 - 2026) Analysis & Trends
Silo Pharma has reported Payables for 13 years, with the latest figure at $632743.0 in Q1 2026.
- Quarterly Payables fell 43.16% year-over-year to $632743.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $632743.0 (down 43.16% YoY) and the FY2025 annual result came in at $578081.0, down 63.5% from the prior year.
- Payables advanced to $632743.0 in Q1 2026 per SILO's latest filing, from $578081.0 in the prior quarter.
- Over five years, Payables peaked at $1.6 million in Q4 2024 and troughed at $155807.0 in Q1 2022.
- A 5-year average of $737804.2 and a median of $669862.5 in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2025: Payables surged 572.18% in 2023, then slumped 63.5% in 2025.
- Over 5 years, Payables stood at $364216.0 in 2022, then jumped by 93.15% to $703488.0 in 2023, then surged by 125.15% to $1.6 million in 2024, then plunged by 63.5% to $578081.0 in 2025, then advanced by 9.46% to $632743.0 in 2026.
- According to Business Quant data, Payables over the past three periods registered $632743.0, $578081.0, and $636237.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Silo Pharma | 2.97 Mn | 2.97 Mn | - | 362,181.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 362,181.00 |
| Mar 31, 2026 | 632,743.00 |
| Dec 31, 2025 | 578,081.00 |
| Sep 30, 2025 | 636,237.00 |
| Jun 30, 2025 | 977,795.00 |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 972,730.00 |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 801,570.00 |
| Dec 31, 2023 | 703,488.00 |
| Sep 30, 2023 | 606,669.00 |
| Jun 30, 2023 | 1.05 Mn |
| Dec 31, 2022 | 364,216.00 |
| Sep 30, 2022 | 223,645.00 |
| Jun 30, 2022 | 155,924.00 |
| Mar 31, 2022 | 155,807.00 |
| Dec 31, 2021 | 835,874.00 |
| Sep 30, 2021 | 211,286.00 |
| Jun 30, 2021 | 192,033.00 |